IMCD stock gains 0.22 percent pre-market to EUR 103.48
Published on 10/14/2026 at 08:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSFinancial calendar and analyst view
- IMCD’s next nine-month results are scheduled for November 5, 2026.
- IMCD stock trades pre-market at EUR 103.48 at 8:20 a.m. CEST at Lang & Schwarz on October 14, 2026, 0.22 percent above the Xetra close of October 13, 2026.
- Goldman Sachs assigned IMCD a EUR 133.00 12-month price target in its October 2, 2026 note.
IMCD stock gains 0.22 percent pre-market to EUR 103.48. At 8:20 a.m. CEST on October 14, 2026, the Lang & Schwarz price was 0.22 percent above the Xetra close of October 13, 2026, at EUR 103.25. The bid was EUR 103.25 and the ask was EUR 103.70.
Pre-market price and trading range
The stock’s current indication is based on the Lang & Schwarz quote in euros before the Xetra session begins. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of IMCD stock.
What matters today
IMCD’s investor-relations calendar lists publication of the company’s first nine months 2026 results for November 5, 2026, according to IMCD investor relations. A round-number reference of EUR 105.00 is 1.47 percent above the Lang & Schwarz price of EUR 103.48. Goldman Sachs assigned IMCD a EUR 133.00 12-month price target in a note published October 2, 2026, while analyst Suhasini Varanasi cited the company’s specialized product mix and additional formulation services in the assessment, as reported by CNBC.
Investor calendar
IMCD’s published schedule also lists full-year 2026 results for February 19, 2027, and the 2026 annual report for March 4, 2027. The company’s investor-relations page identifies IMCD as the listed company and provides financial reports, presentations, press releases and webcast materials for shareholders and analysts.
Market context: Market report AEX.
